Qi Ming (奇铭)奇铭
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 开封康诺药业有限公司Chinese legal name: 开封康诺药业有限公司
主要成分Active Ingredients
- 己酮可可碱Jitong Keke Jian
药物知识说明
己酮可可碱是一种在国家药监局注册认定的药品。该药品含有己酮可可碱-19aa93b6等成分。
该药品关联的活性成分包括:己酮可可碱Jitong Keke Jian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:开封康诺药业有限公司Chinese legal name: 开封康诺药业有限公司。
您可以探索含有相同成分的其他药品:己酮可可碱-19aa93b6成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 奇铭) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 己酮可可碱Jitong Keke Jian.
Manufacturers recorded for this product: 开封康诺药业有限公司Chinese legal name: 开封康诺药业有限公司.
Explore other medicines containing the same ingredient: 己酮可可碱 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 奇铭Recorded Chinese name: 奇铭
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 0.3g0.3 g
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 开封康诺药业有限公司Chinese legal name: 开封康诺药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20040065
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20040065
Manufacturer
Chinese legal name: 开封康诺药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20040065
生产企业
开封康诺药业有限公司(国产)
适应症
1.脑部血循环障碍如暂时性脑缺血发作、中风后遗症、脑缺血引起的脑功能障碍;2.外周血循环障碍性疾病如血栓栓塞性脉管炎、腹部动脉血循环障碍、间歇性跛行或静息痛;3.内耳循环障碍如突发性耳聋、老年性耳鸣及耳聋;4.眼部血循环障碍。
用法用量
静脉滴注,溶于250-500ml0.9%氯化钠注射液或5%葡萄糖注射液中。用时患者应平卧位,初次剂量为己酮可可碱100ml,于2-3小时内输入,最大滴速不可超过100mg/h。根据患者耐受性可每次增加50mg,常用剂量为每次100-200mg,每日1-2次,每次最大用药量不可超过300mg。
不良反应
1.常见的不良反应:恶心、头晕、头痛、厌食、腹胀、呕吐等,其发生率约在5%以上。2.较少见的不良反应有心血管系统:血压降低、呼吸不规则、水肿;神经系统的焦虑、抑郁和抽搐;消化系统的便秘、口干、口渴;皮肤血管性水肿、皮疹、指甲发亮;以及视力模糊、结膜炎、中央盲点扩大、味觉减退、唾液增多、白细胞减少、肌肉酸痛和体重改变等。3.偶见的不良反应有心绞痛、心律不齐;黄疸、肝炎、肝功能异常;血液纤维蛋白原降低和再生不良性贫血等。
禁忌
对己酮可可碱或其它甲磺嘌呤药物过敏者,脑出血患者及广泛视网膜出血者,急性心肌梗塞都昌病人,妊娠期,严重冠状动脉及脑血管硬化伴高血压者,严重的心律失常者禁用本品。
注意事项
低血压、血压不稳或肾功能严重失调患者慎用。
贮藏
遮光,密闭保存。
规格
0.3g
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.